Zorana P. Andric

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics.

Discrimination of Bipolar Disorder and Schizophrenia Patients Based on LC-HRMS Lipidomics.

Journal: Metabolites
Published: November 12, 2025

Identification of the Novel HLA-C*06:44:02 Allele by Next-Generation Sequencing in a Serbian Individual.

Identification of the Novel HLA-C*06:44:02 Allele by Next-Generation Sequencing in a Serbian Individual.

Journal: HLA
Published: December 30, 2024

Impact of human leucocyte antigen class II polymorphism on anti-red blood cell antibody development: Correlations and indications.

Impact of human leucocyte antigen class II polymorphism on anti-red blood cell antibody development: Correlations and indications.

Journal: Vox sanguinis
Published: November 01, 2023

Large-Vessel Giant Cell Arteritis following COVID-19-What Can HLA Typing Reveal?

Large-Vessel Giant Cell Arteritis following COVID-19-What Can HLA Typing Reveal?

Journal: Diagnostics (Basel, Switzerland)
Published: December 08, 2022

Comprehensive Analysis of the HLA Class I and the HLA Class II Alleles in Patients with Takayasu Arteritis: Relationship with Clinical Patterns and Prognosis

Comprehensive Analysis of the HLA Class I and the HLA Class II Alleles in Patients with Takayasu Arteritis: Relationship with Clinical Patterns and Prognosis

Journal: Iranian journal of immunology : IJI
Published: December 21, 2021

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial.

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 01, 2019

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 04, 2018

Human leukocyte antigen class II (DRB1 and DQB1) alleles and haplotypes frequencies in patients with pemphigus vulgaris among the Serbian population.

Human leukocyte antigen class II (DRB1 and DQB1) alleles and haplotypes frequencies in patients with pemphigus vulgaris among the Serbian population.

Journal: HLA
Published: December 08, 2015

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 20, 2015

High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.

High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.

Journal: European journal of neurology
Published: September 12, 2013

HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in the Serbian population.

HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in the Serbian population.

Journal: Human immunology
Published: July 11, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026